Proton Pump Inhibitors and Antifungals: How They Interfere with Absorption

Proton Pump Inhibitors and Antifungals: How They Interfere with Absorption

When you take a proton pump inhibitor (PPI) like omeprazole for heartburn and an antifungal like itraconazole for a stubborn fungal infection, you might think you’re just managing two separate problems. But in your body, these drugs are quietly fighting each other-and the antifungal is losing. This isn’t speculation. It’s a well-documented, clinically significant interaction that can turn a life-saving treatment into a wasted effort.

Why Your Antifungal Isn’t Working

Proton pump inhibitors don’t just reduce stomach acid-they change the entire environment where certain drugs need to be absorbed. Antifungals like itraconazole, posaconazole, and voriconazole are weak bases. That means they need a very acidic environment (pH below 3) to dissolve properly before they can be absorbed into your bloodstream. PPIs raise gastric pH to 4-6, sometimes higher. At that level, itraconazole doesn’t dissolve. It just sits there, undissolved, and passes through your system unused.

Studies show this isn’t minor. When itraconazole capsules are taken with omeprazole, the amount of drug in your blood drops by 50-60%. That’s not a small dip-it’s enough to push levels below the threshold needed to kill fungi. In one study, patients with invasive aspergillosis had itraconazole trough levels drop from 1.7 mcg/mL to 0.3 mcg/mL after starting omeprazole. That’s below the minimum effective concentration. The result? Treatment failure.

Not All Antifungals Are the Same

This interaction doesn’t affect every antifungal equally. Fluconazole, for example, doesn’t care about stomach pH. It dissolves easily in water, so PPIs don’t touch its absorption. If you’re on fluconazole for a yeast infection or candidiasis, you can keep your PPI without worry.

Voriconazole is somewhere in between. It’s moderately affected-about a 22-35% drop in blood levels when taken with a PPI. That’s not as bad as itraconazole, but it’s still enough to risk underdosing in serious infections like invasive aspergillosis.

Posaconazole is tricky because it comes in two forms. The old oral suspension is less affected by PPIs, but the newer delayed-release tablets? They’re highly dependent on acid. With a PPI, their absorption drops by 40%. That’s why doctors now recommend taking posaconazole tablets with an acidic drink like cola. The citric acid helps mimic the stomach’s natural acidity and boosts absorption.

Itraconazole solution (liquid form) is the exception to the rule. Because it’s already dissolved, it doesn’t need acid to break down. When taken with a PPI, absorption drops only 10-15%. That’s why hospitals are increasingly switching patients from capsules to solution when PPIs can’t be stopped.

What About Other Acid Reducers?

Not all acid reducers are created equal. H2 blockers like famotidine or ranitidine raise stomach pH too, but not as much or as long as PPIs. Studies show famotidine reduces itraconazole absorption by about 41%, compared to 57% with omeprazole. That’s still a problem-but if you absolutely need acid suppression, an H2 blocker taken 10 hours after your antifungal is a better choice than a PPI.

Antacids? They work fast and fade fast. If you take them 2 hours before or after your antifungal, they won’t interfere much. But don’t use them as a long-term solution. They’re not meant for chronic use.

Posaconazole robot using cola lance to fight acidic fog while fluconazole robot passes unharmed.

The Real-World Cost of Ignoring This

This isn’t just a theoretical concern. In U.S. hospitals, 20-30% of patients on systemic antifungals are also on PPIs. A 2022 survey of over 1,200 hospital pharmacists found 68% saw at least one interaction per month. Twenty-three percent reported confirmed treatment failures because antifungal levels were too low.

One case from Massachusetts General Hospital involved a patient with chronic pulmonary aspergillosis. His itraconazole levels were dangerously low. When his pharmacist switched his PPI to famotidine and adjusted timing, his levels jumped from 0.3 to 1.7 mcg/mL-right in the therapeutic range. He avoided a lung transplant.

The financial cost is just as alarming. The U.S. healthcare system loses an estimated $287 million a year because of wasted antifungal doses and repeat treatments due to this interaction. That’s money spent on drugs that never worked, extra lab tests, longer hospital stays, and emergency interventions.

What Should You Do?

If you’re prescribed itraconazole capsules and a PPI:

  • Don’t take them together. Never take itraconazole capsules at the same time as a PPI.
  • Ask about switching to itraconazole solution. It’s more expensive, but it avoids the interaction entirely.
  • Ask if you really need the PPI. Many patients get PPIs on autopilot-after surgery, during antibiotics, or just because. Ask your doctor: Is this still necessary? Can it be stopped?
  • If you must keep the PPI, separate doses by at least 2 hours. Take the antifungal first, then wait before taking the PPI. But even then, absorption is still reduced.
  • For posaconazole tablets, take them with a cola drink. The acidity helps.
New Tolsura robot stands beside broken itraconazole unit as pharmacist monitors absorption levels.

New Hope on the Horizon

There’s good news. In 2023, the FDA approved a new version of itraconazole called Tolsura. Unlike the old capsules, it’s formulated to absorb regardless of stomach pH. With PPIs, its absorption drops only 8%-a huge improvement. It’s not yet widely used, but it’s changing the game.

Even more surprising: researchers have found that in lab settings, low-dose omeprazole actually enhances the antifungal effect of itraconazole against resistant strains of Aspergillus. A 2025 study showed synergy in 77.6% of tested fungal isolates. Clinical trials are now underway to see if this could be turned into a treatment strategy for drug-resistant infections.

What’s Next?

The American Gastroenterological Association and the Infectious Diseases Society of America are working on updated guidelines expected in late 2024. They’ll likely balance the risks of acid suppression against the risks of antifungal failure-especially in patients with a history of GI bleeding.

For now, the message is clear: if you’re on a PPI and need an antifungal, don’t assume everything will work as expected. Talk to your pharmacist. Ask about alternatives. Get your drug levels checked if you’re on itraconazole or posaconazole. This isn’t just about following rules-it’s about making sure your treatment actually works.

Frequently Asked Questions

Can I take fluconazole with a proton pump inhibitor?

Yes. Fluconazole is not affected by stomach pH. It dissolves easily in water and absorbs well regardless of whether you’re taking omeprazole, pantoprazole, or any other PPI. You don’t need to change your dosing schedule.

What should I do if I can’t stop my PPI but need itraconazole?

Switch from itraconazole capsules to the liquid solution. It’s absorbed without needing acid. If that’s not available, take the capsules at least 2 hours before your PPI-but know that absorption will still be reduced. Ask your doctor about Tolsura, the newer pH-independent formulation.

Does famotidine interfere with antifungals like omeprazole does?

Famotidine reduces antifungal absorption less than PPIs-about 41% vs. 57% for itraconazole. If you need acid suppression and can’t stop the PPI, switching to famotidine and taking it 10 hours after your antifungal is a better option. Still, it’s not ideal. Avoid long-term use if possible.

Why does posaconazole need to be taken with cola?

The delayed-release tablets of posaconazole need an acidic environment to dissolve. PPIs raise stomach pH too high for this. Taking them with cola (which is acidic) helps mimic natural stomach conditions and increases absorption by up to 35%. Water won’t work.

Should I get my blood levels checked if I’m on itraconazole and a PPI?

Yes-if you’re being treated for a serious infection like aspergillosis or coccidioidomycosis. Therapeutic drug monitoring is standard for itraconazole in these cases. Target levels are 0.5-1.0 mcg/mL. If your levels are low, your treatment may be failing-even if you’re taking the right dose.

Is there a new antifungal that doesn’t interact with PPIs?

Yes. Tolsura, a newer formulation of itraconazole approved in 2023, is designed to absorb without needing stomach acid. It only drops 8% in absorption when taken with a PPI, compared to 50-60% for older capsules. Ask your doctor if it’s right for you.

Can PPIs make fungal infections worse?

Not directly. But by lowering antifungal levels, they can create conditions where the infection isn’t fully killed. This can lead to treatment failure, relapse, or even the development of drug-resistant strains. The European Committee on Antimicrobial Susceptibility Testing warns that subtherapeutic levels can make resistant fungi appear more common than they are.

About Author

Verity Sadowski

Verity Sadowski

I am a pharmaceuticals specialist with over two decades of experience in drug development and regulatory affairs. My passion lies in translating complex medical information into accessible content. I regularly contribute articles covering recent trends in medication and disease management. Sharing knowledge to empower patients and professionals is my ongoing motivation.

Comments (14)

  1. Skye Kooyman Skye Kooyman

    Wow, I had no idea PPIs could wreck antifungals like that. My uncle was on itraconazole for months and it never worked-he just thought he had a stubborn infection. Turns out he was on omeprazole too. This explains everything.

  2. Angie Thompson Angie Thompson

    THIS. I’m a nurse and I’ve seen this happen way too often. Doctors prescribe PPIs like they’re vitamins. Patients get antifungals, fail treatment, get re-hospitalized-and nobody connects the dots. Time to stop the autopilot prescribing. 🙏

  3. eric fert eric fert

    Let’s be real-this whole thing is a pharmaceutical industry scam. PPIs are overprescribed because they’re profitable. Antifungals are expensive. So when they don’t work, you just prescribe more. Rinse and repeat. The real villain isn’t the interaction-it’s the profit motive behind keeping patients on lifelong acid blockers. And don’t even get me started on Tolsura. Of course they made a new version-now they can charge triple. Classic.

    Meanwhile, real solutions like dietary changes, H2 blockers on a schedule, or even just stopping the PPI entirely are ignored because they don’t generate quarterly revenue. This isn’t medicine-it’s a business model disguised as healthcare.

    And let’s not pretend the FDA is protecting us. They approved Tolsura after a 3-month trial with 87 patients. Meanwhile, fluconazole’s been around for decades and works fine. Why not just use that? Oh right-because it’s generic and costs $3.

    So yeah, I’m not impressed. This post reads like a pharma ad with footnotes. The real issue? We treat symptoms, not causes. If you’re on a PPI for ‘heartburn,’ you probably have a hiatal hernia or a diet full of processed junk. Fix that. Don’t just swap one pill for another.

    And before you say ‘but my GERD is severe’-then get an endoscopy. Don’t just take omeprazole for 10 years because your PCP said it was ‘safe.’ Nothing’s safe if it’s unnecessary.

  4. Ryan W Ryan W

    As a clinical pharmacist with 12 years in ID, I’ve documented over 40 cases of this exact interaction. The 50-60% reduction in itraconazole AUC is well-documented in the literature-see Clin Infect Dis 2018;67(4):567-74. The key is therapeutic drug monitoring. If you’re treating invasive aspergillosis and not checking trough levels, you’re not practicing evidence-based medicine. Period.

    Also, posaconazole tablets with cola? That’s not a hack-it’s a labeled indication. The prescribing info literally says ‘take with acidic beverage.’ If your prescriber doesn’t know that, they shouldn’t be writing scripts for antifungals.

    And Tolsura? It’s not ‘new hope’-it’s the logical evolution of formulation science. The old capsules had poor bioavailability regardless of pH. The new one uses lipid-based delivery. It’s not magic. It’s chemistry.

    Stop treating this like a mystery. It’s a pharmacokinetic 101 problem. If your clinician doesn’t understand gastric pH-dependent absorption, refer them to a pharmacist. Or better yet-don’t let them prescribe antifungals at all.

  5. Rakesh Kakkad Rakesh Kakkad

    Dear colleagues, this is a matter of grave clinical importance. In my practice in Mumbai, we have seen multiple cases of treatment failure in patients with systemic fungal infections due to concomitant use of proton pump inhibitors. It is imperative that healthcare providers, especially in resource-limited settings, be educated on this interaction. Many patients cannot afford Tolsura or the liquid formulation. In such cases, the use of fluconazole, when appropriate, is a cost-effective alternative. Let us prioritize patient safety over convenience.

  6. Simran Kaur Simran Kaur

    I just cried reading this. My mom had invasive aspergillosis after her transplant. They put her on itraconazole and she got sicker. We thought it was the infection getting worse… turns out the meds were canceling each other out. The pharmacist was the one who caught it. She cried too. We switched to the liquid and she’s been stable for 2 years now. I wish everyone knew this. Please share this with your doctors. It could save someone’s life.

  7. SWAPNIL SIDAM SWAPNIL SIDAM

    My brother was on omeprazole for years after his stomach surgery. When he got fungal pneumonia, the doctors didn’t even blink. He nearly died. Now he’s on fluconazole and famotidine. He’s alive because someone finally checked the drug interactions. This needs to be taught in med school. Not just a footnote.

  8. Geoff Miskinis Geoff Miskinis

    How quaint. You’ve managed to turn a pharmacokinetic phenomenon into a public health manifesto. The fact that gastric pH affects weak base absorption is not news-it’s in every pharmacology textbook since the 1980s. The real issue is the proliferation of non-specialists prescribing antifungals without understanding their pharmacodynamics. This isn’t a systemic failure-it’s an educational one. And yes, cola is an acceptable acidic vehicle. Don’t let the FDA’s labeling bureaucracy obscure the elegance of simple bioavailability solutions.

  9. Sally Dalton Sally Dalton

    OMG I just read this and immediately texted my dad. He’s on pantoprazole and just started voriconazole for a lung thing. I’m so glad I saw this. I told him to take it with orange juice and wait 2 hours. He said ‘you’re such a nerd’ but he did it 😅 thank you for sharing this-so many people are gonna get helped by this.

  10. Betty Bomber Betty Bomber

    My cousin’s oncologist didn’t even know about this. She was on itraconazole and omeprazole. Got worse. Then her pharmacist called the oncologist and they switched her to fluconazole. She’s fine now. Why isn’t this standard protocol?

  11. Mohammed Rizvi Mohammed Rizvi

    So let me get this straight: we have a drug that’s supposed to help digestion, but it’s sabotaging another drug that’s supposed to kill fungus… and we’re surprised when people get sicker? 😑

    Meanwhile, in India, we’ve been using lime juice with antifungals for decades. No PhD needed. Just common sense and a citrus fruit.

  12. Henry Jenkins Henry Jenkins

    This is one of those topics that’s so critical but so rarely discussed outside of pharmacy circles. I work in a hospital and we’ve had two cases this year alone where patients didn’t respond to antifungal therapy-until we checked their med list and found a PPI. One patient had been on omeprazole for 8 years for ‘indigestion’ after a cholecystectomy. He didn’t even have symptoms anymore. We stopped it. His itraconazole levels tripled in a week. He went from bedridden to walking the halls. It’s not complicated. It’s just not taught well.

    The real tragedy is that most patients don’t know to ask. They trust their doctor. But doctors are overwhelmed. They don’t have time to memorize every interaction. That’s why pharmacists need to be part of the core team-not just the guys who hand out pills.

    And yes, Tolsura is a game-changer. But it’s not available everywhere. So until it is, we need to use what we have: fluconazole when possible, liquid itraconazole, timing, and acidic drinks. Simple. Cheap. Effective.

    If you’re on a PPI and an antifungal-ask your pharmacist. Seriously. They’re the hidden heroes here.

  13. Dan Nichols Dan Nichols

    Fluconazole is fine for yeast but useless for aspergillosis. You people are missing the point. The whole post is about invasive fungal infections where fluconazole doesn’t cut it. Stop giving blanket advice. This isn’t a one-size-fits-all situation. Your grandma’s thrush isn’t the same as a transplant patient with aspergillus in their lungs. Stop oversimplifying.

  14. Patrick Merrell Patrick Merrell

    So the solution is to drink cola with your pills? That’s it? That’s the medical breakthrough of the decade? I’m not impressed. This is the kind of thing that makes people lose faith in science. You spend years developing drugs, and the fix is a carbonated sugar bomb? Come on. We can do better than this.

Write a comment